Tag Archives: Rexahn Pharmaceuticals Inc.

Md. biopharm shows profit, continues studies of cancer drug

(ml12nan / Depositphotos.com)

Rexahn Pharmaceuticals Inc., a Rockville biopharmaceutical company, had a profit in its second quarter because of accounting adjustments resulting from a change in stock price. Taking into account an upward adjustment of $5.5 million in an unrealized gain on the fair ...

Read More »